阳光诺和(688621.SH)拟1500万元参投缴元码智药

Core Viewpoint - Yangguang Nuohuo (688621.SH) plans to invest 15 million yuan in Yuanma Zhiyao to increase its registered capital by 110,556 yuan, resulting in an 8.20% equity stake in the company. This move aims to advance the overall strategic layout in the fields of in vivo CAR-T cell therapy and nucleic acid drugs [1] Group 1 - The investment amount is 15 million yuan [1] - The registered capital increase is 110,556 yuan [1] - The resulting equity stake in Yuanma Zhiyao will be 8.20% [1] Group 2 - The strategic focus is on in vivo CAR-T cell therapy and nucleic acid drugs [1]